Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Workforce Diversity and Team Effectiveness: Insights from the Construction Sector in Ghana

workforce diversity

Kwofie TE, Awuni M, Coffie RB.
GSID: 74awCrNVY6YJ
F Ellis, TE Kwofie, M Awuni, RB Coffie… - … of Business Diversity, 2019 - researchgate.net

… In the first section, we review the literature by discussing the three theories underlying the concept of diversity and we attempt to integrate empirical research on workforce diversity and its influence on team effectiveness. In the second section,...

Cite
Ellis, F., Kwofie, T. E., Awuni, M., Coffie, R. B., & Duffour, M. (2019). Workforce Diversity and Team Effectiveness: Insights from the Construction Sector in Ghana. Journal of Business Diversity, 19(5).
Ellis, Florence, et al. "Workforce Diversity and Team Effectiveness: Insights from the Construction Sector in Ghana." Journal of Business Diversity 19.5 (2019).
Copy Download .nbib Format: MLA
Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?.

Nature clinical practice. Oncology

Coiffier B.
PMID: 16130931
Nat Clin Pract Oncol. 2005 Aug;2(8):388-9. doi: 10.1038/ncponc0229.

No abstract available.

Cite
Coiffier B. Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?. Nat Clin Pract Oncol. 2005;2(8):388-9doi: 10.1038/ncponc0229.
Coiffier, B. (2005). Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?. Nature clinical practice. Oncology, 2(8), 388-9. https://doi.org/10.1038/ncponc0229
Coiffier, Bertrand. "Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?." Nature clinical practice. Oncology vol. 2,8 (2005): 388-9. doi: https://doi.org/10.1038/ncponc0229
Coiffier B. Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?. Nat Clin Pract Oncol. 2005 Aug;2(8):388-9. doi: 10.1038/ncponc0229. PMID: 16130931.
Copy Download .nbib Format: NLM
Conjunctival lymphatic response to corneal inflammation in mice.

Journal of ophthalmology

Ecoiffier T, Sadovnikova A, Yuen D, Chen L.
PMID: 22523656
J Ophthalmol. 2012;2012:953187. doi: 10.1155/2012/953187. Epub 2012 Mar 15.

Due to its unique characteristics, the cornea has been widely used for vascular research. However, it has never been studied whether lymphatic vessels in the conjunctiva, its neighboring tissue, are affected by corneal lymphangiogenesis (LG). The purpose of this...

Cite
Ecoiffier T, Sadovnikova A, Yuen D, et al. Conjunctival lymphatic response to corneal inflammation in mice. J Ophthalmol. 2012;2012:953187doi: 10.1155/2012/953187.
Ecoiffier, T., Sadovnikova, A., Yuen, D., & Chen, L. (2012). Conjunctival lymphatic response to corneal inflammation in mice. Journal of ophthalmology, 2012953187. https://doi.org/10.1155/2012/953187
Ecoiffier, Tatiana, et al. "Conjunctival lymphatic response to corneal inflammation in mice." Journal of ophthalmology vol. 2012 (2012): 953187. doi: https://doi.org/10.1155/2012/953187
Ecoiffier T, Sadovnikova A, Yuen D, Chen L. Conjunctival lymphatic response to corneal inflammation in mice. J Ophthalmol. 2012;2012:953187. doi: 10.1155/2012/953187. Epub 2012 Mar 15. PMID: 22523656; PMCID: PMC3317212.
Copy Download .nbib Format: NLM
Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Flais J, Coiffier G, Brillet E, Perdriger A, Guggenbuhl P.
PMID: 29263741
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):239-240. doi: 10.11138/ccmbm/2017.14.1.239. Epub 2017 Oct 25.

A 55-year-old man was hospitalized for a low back pain lasting for 3 months. Spinal MRI revealed a suggestive aspect of multilevel discitis L5-S1-S2 with paravertebral abscess. A thoraco-abdominal CT scan confirmed the presence of multiple pathological lymph nodes...

Cite
Flais J, Coiffier G, Brillet E, et al. Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease. Clin Cases Miner Bone Metab. 2017;14(2):239-240doi: 10.11138/ccmbm/2017.14.1.239.
Flais, J., Coiffier, G., Brillet, E., Perdriger, A., & Guggenbuhl, P. (2017). Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 14(2), 239-240. https://doi.org/10.11138/ccmbm/2017.14.1.239
Flais, Jérémy, et al. "Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 14,2 (2017): 239-240. doi: https://doi.org/10.11138/ccmbm/2017.14.1.239
Flais J, Coiffier G, Brillet E, Perdriger A, Guggenbuhl P. Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott's disease. Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):239-240. doi: 10.11138/ccmbm/2017.14.1.239. Epub 2017 Oct 25. PMID: 29263741; PMCID: PMC5726217.
Copy Download .nbib Format: NLM
[Not Available].

Annals of burns and fire disasters

Girbon JP, Maligot B, Coiffier E, Gonzalez-Gutierrez L, Gaussorgues C, Lacroix P, Braye F.
PMID: 21991119
Ann Burns Fire Disasters. 2008 Jun 30;21(2):94-101.

The incorrect position of the foot in talipes equinus is common in the framework of prolonged confinement to bed in a patient in deep sedation. In the context of severe burns, this incorrect position is difficult to prevent and...

Cite
Girbon JP, Maligot B, Coiffier E, et al. L'Equin du Pied dans un Contexte de Brulure Grave - Interet du Bilan Photographique. [Not Available]. Ann Burns Fire Disasters. 2008;21(2):94-101
Girbon, J. P., Maligot, B., Coiffier, E., Gonzalez-Gutierrez, L., Gaussorgues, C., Lacroix, P., & Braye, F. (2008). L'Equin du Pied dans un Contexte de Brulure Grave - Interet du Bilan Photographique. [Not Available]. Annals of burns and fire disasters, 21(2), 94-101.
Girbon, J P, et al. "L'Equin du Pied dans un Contexte de Brulure Grave - Interet du Bilan Photographique." [Not Available]. Annals of burns and fire disasters vol. 21,2 (2008): 94-101.
Girbon JP, Maligot B, Coiffier E, Gonzalez-Gutierrez L, Gaussorgues C, Lacroix P, Braye F. L'Equin du Pied dans un Contexte de Brulure Grave - Interet du Bilan Photographique. [Not Available]. Ann Burns Fire Disasters. 2008 Jun 30;21(2):94-101. French. PMID: 21991119; PMCID: PMC3188157.
Copy Download .nbib Format: NLM
Lyme arthritis in Western Europe: a multicentre retrospective study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Corre C, Coiffier G, Le Goff B, Ferreyra M, Guennic X, Patrat-Delon S, Degeilh B, Albert JD, Tattevin P.
PMID: 34417687
Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):21-27. doi: 10.1007/s10096-021-04334-y. Epub 2021 Aug 20.

To characterize Lyme arthritis, with a focus on management, and outcome. Observational retrospective multicentre study in Western France, of all consecutive cases of Lyme arthritis, documented by Borrelia burgdorferi IgG on ELISA serological testing, confirmed by Western blot, with...

Cite
Corre C, Coiffier G, Le Goff B, et al. Lyme arthritis in Western Europe: a multicentre retrospective study. Eur J Clin Microbiol Infect Dis. 2021;41(1):21-27doi: 10.1007/s10096-021-04334-y.
Corre, C., Coiffier, G., Le Goff, B., Ferreyra, M., Guennic, X., Patrat-Delon, S., Degeilh, B., Albert, J. D., & Tattevin, P. (2022). Lyme arthritis in Western Europe: a multicentre retrospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 41(1), 21-27. https://doi.org/10.1007/s10096-021-04334-y
Corre, Clémence, et al. "Lyme arthritis in Western Europe: a multicentre retrospective study." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 41,1 (2022): 21-27. doi: https://doi.org/10.1007/s10096-021-04334-y
Corre C, Coiffier G, Le Goff B, Ferreyra M, Guennic X, Patrat-Delon S, Degeilh B, Albert JD, Tattevin P. Lyme arthritis in Western Europe: a multicentre retrospective study. Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):21-27. doi: 10.1007/s10096-021-04334-y. Epub 2021 Aug 20. PMID: 34417687.
Copy Download .nbib Format: NLM
Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Lloret A, Coiffier G, Couchouron T, Perdriger A, Guggenbuhl P.
PMID: 27920808
Clin Cases Miner Bone Metab. 2016 May-Aug;13(2):123-126. doi: 10.11138/ccmbm/2016.13.2.123. Epub 2016 Oct 05.

INTRODUCTION: Osteoporotic fractures are a major public health problem because of the morbidity and mortality of fracture complications. The objective of this study was to examine predictive factors of mortality during the first year after an osteoporotic fracture.METHODS: It...

Cite
Lloret A, Coiffier G, Couchouron T, et al. Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study. Clin Cases Miner Bone Metab. 2016;13(2):123-126doi: 10.11138/ccmbm/2016.13.2.123.
Lloret, A., Coiffier, G., Couchouron, T., Perdriger, A., & Guggenbuhl, P. (2016). Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 13(2), 123-126. https://doi.org/10.11138/ccmbm/2016.13.2.123
Lloret, Aurore, et al. "Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 13,2 (2016): 123-126. doi: https://doi.org/10.11138/ccmbm/2016.13.2.123
Lloret A, Coiffier G, Couchouron T, Perdriger A, Guggenbuhl P. Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study. Clin Cases Miner Bone Metab. 2016 May-Aug;13(2):123-126. doi: 10.11138/ccmbm/2016.13.2.123. Epub 2016 Oct 05. PMID: 27920808; PMCID: PMC5119709.
Copy Download .nbib Format: NLM
Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle.

Leukemia & lymphoma

Cornillet P, Rimokh R, Berger F, Ffrench M, Rouault JP, Wahbi K, Bryon PA, Gentilhomme O, Coiffier B, Germain D, Magaud JP.
PMID: 27467668
Leuk Lymphoma. 1991;4(5):355-62. doi: 10.3109/10428199109068086.

The t(14;18) chromosomal translocation is widely recognized as a cytogenetic abnormality associated with follicular lymphomas, but estimates of its frequency in this type of lymphoma vary from less than 40% to almost 90% according to the geographic origin of...

Cite
Cornillet P, Rimokh R, Berger F, et al. Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle. Leuk Lymphoma. 1991;4(5):355-62doi: 10.3109/10428199109068086.
Cornillet, P., Rimokh, R., Berger, F., Ffrench, M., Rouault, J. P., Wahbi, K., Bryon, P. A., Gentilhomme, O., Coiffier, B., Germain, D., & Magaud, J. P. (1991). Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle. Leukemia & lymphoma, 4(5), 355-62. https://doi.org/10.3109/10428199109068086
Cornillet, P, et al. "Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle." Leukemia & lymphoma vol. 4,5 (1991): 355-62. doi: https://doi.org/10.3109/10428199109068086
Cornillet P, Rimokh R, Berger F, Ffrench M, Rouault JP, Wahbi K, Bryon PA, Gentilhomme O, Coiffier B, Germain D, Magaud JP. Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell Cycle. Leuk Lymphoma. 1991;4(5):355-62. doi: 10.3109/10428199109068086. PMID: 27467668.
Copy Download .nbib Format: NLM
Diagnostic performances of ultrasound evaluation of major salivary glands according to the 2019 OMERACT US scoring system.

Arthritis care & research

Robin F, Albert JD, Lescoat A, Martel A, Perdriger A, DeBandt M, Maillot F, Coiffier G.
PMID: 33973395
Arthritis Care Res (Hoboken). 2021 May 10; doi: 10.1002/acr.24631. Epub 2021 May 10.

OBJECTIVE: To evaluate the diagnostic performance of ultrasound examination of the major salivary glands (US-SG) according to the 2019 OMERACT US scoring system for Sjogren's syndrome (SS).METHODS: This was a retrospective study based on a multicentric cohort of SS/sicca...

Cite
Robin F, Albert JD, Lescoat A, et al. Diagnostic performances of ultrasound evaluation of major salivary glands according to the 2019 OMERACT US scoring system. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24631.
Robin, F., Albert, J. D., Lescoat, A., Martel, A., Perdriger, A., DeBandt, M., Maillot, F., & Coiffier, G. (2021). Diagnostic performances of ultrasound evaluation of major salivary glands according to the 2019 OMERACT US scoring system. Arthritis care & research, . https://doi.org/10.1002/acr.24631
Robin, François, et al. "Diagnostic performances of ultrasound evaluation of major salivary glands according to the 2019 OMERACT US scoring system." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24631
Robin F, Albert JD, Lescoat A, Martel A, Perdriger A, DeBandt M, Maillot F, Coiffier G. Diagnostic performances of ultrasound evaluation of major salivary glands according to the 2019 OMERACT US scoring system. Arthritis Care Res (Hoboken). 2021 May 10; doi: 10.1002/acr.24631. Epub 2021 May 10. PMID: 33973395.
Copy Download .nbib Format: NLM
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.

Hematological oncology

Filliatre-Clement L, Maucort-Boulch D, Bourbon E, Karlin L, Safar V, Bachy E, Sesques P, Ferrant E, Bouafia F, Lazareth A, Ghergus D, Coiffier B, Traverse Glehen A, Salles G, Ghesquieres H, Sarkozy C.
PMID: 29722049
Hematol Oncol. 2018 May 02; doi: 10.1002/hon.2512. Epub 2018 May 02.

In the rituximab era, one-third of diffuse large B-cell lymphoma patients experience relapse/refractory disease after first-line anthracycline-based immunochemotherapy. Optimal management remains an unmet medical need. The aim of this study was to report the outcomes of a cohort of...

Cite
Filliatre-Clement L, Maucort-Boulch D, Bourbon E, et al. Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes. Hematol Oncol. 2018;doi: 10.1002/hon.2512.
Filliatre-Clement, L., Maucort-Boulch, D., Bourbon, E., Karlin, L., Safar, V., Bachy, E., Sesques, P., Ferrant, E., Bouafia, F., Lazareth, A., Ghergus, D., Coiffier, B., Traverse Glehen, A., Salles, G., Ghesquieres, H., & Sarkozy, C. (2018). Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes. Hematological oncology, . https://doi.org/10.1002/hon.2512
Filliatre-Clement, Lauriane, et al. "Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes." Hematological oncology vol. (2018). doi: https://doi.org/10.1002/hon.2512
Filliatre-Clement L, Maucort-Boulch D, Bourbon E, Karlin L, Safar V, Bachy E, Sesques P, Ferrant E, Bouafia F, Lazareth A, Ghergus D, Coiffier B, Traverse Glehen A, Salles G, Ghesquieres H, Sarkozy C. Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes. Hematol Oncol. 2018 May 02; doi: 10.1002/hon.2512. Epub 2018 May 02. PMID: 29722049.
Copy Download .nbib Format: NLM
Rituximab in the treatment of diffuse large B-cell lymphomas.

Seminars in oncology

Coiffier B.
PMID: 28140089
Semin Oncol. 2002 Feb;29(1):30-35. doi: 10.1053/sonc.2002.30153.

A review of the use of rituximab (Rituxan; Genentech, Inc, South San Francisco, CA, and IDEC Pharmaceuticals, San Diego, CA) in diffuse large B-cell lymphomas is presented, focusing on the recent presentation of the combination of CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) plus...

Cite
Coiffier B. Rituximab in the treatment of diffuse large B-cell lymphomas. Semin Oncol. 2002;29(1):30-35doi: 10.1053/sonc.2002.30153.
Coiffier, B. (2002). Rituximab in the treatment of diffuse large B-cell lymphomas. Seminars in oncology, 29(1), 30-35. https://doi.org/10.1053/sonc.2002.30153
Coiffier, Bertrand. "Rituximab in the treatment of diffuse large B-cell lymphomas." Seminars in oncology vol. 29,1 (2002): 30-35. doi: https://doi.org/10.1053/sonc.2002.30153
Coiffier B. Rituximab in the treatment of diffuse large B-cell lymphomas. Semin Oncol. 2002 Feb;29(1):30-35. doi: 10.1053/sonc.2002.30153. PMID: 28140089.
Copy Download .nbib Format: NLM
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.

Biomarker research

Foss F, Coiffier B, Horwitz S, Pro B, Prince HM, Sokol L, Greenwood M, Lerner A, Caballero D, Baran E, Kim E, Nichols J, Balser B, Wolfson J, Whittaker S.
PMID: 25279222
Biomark Res. 2014 Sep 08;2:16. doi: 10.1186/2050-7771-2-16. eCollection 2014.

BACKGROUND: Histone deacetylase inhibitor romidepsin has demonstrated durable clinical responses and tolerability in patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma (PTCL, CTCL). Selection of novel drug therapies for patients with relapsed/refractory aggressive lymphoma requires not only considerations regarding...

Cite
Foss F, Coiffier B, Horwitz S, et al. Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma. Biomark Res. 2014;2:16doi: 10.1186/2050-7771-2-16.
Foss, F., Coiffier, B., Horwitz, S., Pro, B., Prince, H. M., Sokol, L., Greenwood, M., Lerner, A., Caballero, D., Baran, E., Kim, E., Nichols, J., Balser, B., Wolfson, J., & Whittaker, S. (2014). Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma. Biomarker research, 216. https://doi.org/10.1186/2050-7771-2-16
Foss, Francine, et al. "Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma." Biomarker research vol. 2 (2014): 16. doi: https://doi.org/10.1186/2050-7771-2-16
Foss F, Coiffier B, Horwitz S, Pro B, Prince HM, Sokol L, Greenwood M, Lerner A, Caballero D, Baran E, Kim E, Nichols J, Balser B, Wolfson J, Whittaker S. Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma. Biomark Res. 2014 Sep 08;2:16. doi: 10.1186/2050-7771-2-16. eCollection 2014. PMID: 25279222; PMCID: PMC4181623.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries